|Prof Dolores J Schendel (CEO), Dave Lemus (COO), Horst Domdey (Chairman of the supervisory board)|
Medigene AG is a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative, complementary treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. Medigene concentrates on the development of personalized T cell-based immunotherapies.
For more information, please visit www.medigene.com
- Official website (German)
|This German corporation or company article is a stub. You can help Wikipedia by expanding it.|